Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q96QD8
UPID:
S38A2_HUMAN
Alternative names:
Amino acid transporter A2; Protein 40-9-1; Solute carrier family 38 member 2; System A amino acid transporter 2; System A transporter 1; System N amino acid transporter 2
Alternative UPACC:
Q96QD8; Q6IA88; Q6ZMG2; Q9HAV3; Q9NVA8; Q9P2G5
Background:
Sodium-coupled neutral amino acid symporter 2, also known as Solute carrier family 38 member 2, plays a crucial role in transporting neutral amino acids and sodium ions across cell membranes. This process is vital for maintaining amino acid levels in the brain and placenta, supporting fetal development, and regulating neurotransmitter glutamate levels for proper brain function. Its ability to transport L-proline is essential for bone formation and osteoblast differentiation.
Therapeutic significance:
Understanding the role of Sodium-coupled neutral amino acid symporter 2 could open doors to potential therapeutic strategies. Its involvement in amino acid transport and neurotransmitter balance highlights its potential as a target in treating neurological disorders and bone development abnormalities.